Our qPCR study reveals that pro-inflammatory markers previously associated with AD (e.g., Il-1β, and Ccl2) are the only genes significantly upregulated at 2 months, possibly signifying the early response of the system to incipient Aβ production. This evidence concerns the gene IL1B and Alzheimer disease.